PMC:7219429 / 487-646
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T4 | 31-43 | Body_part | denotes | gangliosides | http://purl.org/sig/ont/fma/fma82816 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T4 | 111-119 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T5 | 122-131 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T8 | 3-21 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
T9 | 31-43 | Chemical | denotes | gangliosides | http://purl.obolibrary.org/obo/CHEBI_28892 |
T10 | 66-78 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T8 | 44-131 | Sentence | denotes | • Hydroxychloroquine/azithromycin have synergistic effect against SARS-CoV-2 infection |
T9 | 133-141 | Sentence | denotes | Abstract |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
26 | 3-21 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
27 | 31-43 | Chemical | denotes | gangliosides | MESH:D005732 |
31 | 47-65 | Chemical | denotes | Hydroxychloroquine | MESH:D006886 |
32 | 66-78 | Chemical | denotes | azithromycin | MESH:D017963 |
33 | 111-131 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |